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CObjective: Depressive disorders influence socioeconomic burden at
both the individual and organizational levels. This study estimates the
lost productive time (LPT) and its resulting cost among workers with
major depressive disorder (MDD) compared with a comparison group.
It also estimates the change in productivity after 8 weeks of outpatient
psychiatric treatment with antidepressants. Methods: Working pa-
tients diagnosed with MDD without other major physical or mental
disorders were recruited (n  102), along with age- and sex-matched
healthy controls from the Seoul Metropolitan area (n  91). The World
Health Organization’s Health and Work Performance Questionnaire
and the Hamilton Rating Scale for Depression were utilized tomeasure
productivity and severity of depression, respectively, at baseline and at
8 weeks of treatment. Results: The LPT from absenteeism and
resenteeism (reduced performance while present at work) was sig-
ificantly higher among the MDD group. Workers with MDD aver- O
hiatr
al So
doi:10.1016/j.jval.2010.11.006ged costs due to LPT at 33.4% of their average annual salary,
hereas the comparison group averaged costs of 2.5% of annual
alary. After 8 weeks of treatment, absenteeism and clinical symp-
oms of depression were significantly reduced and associated with
ignificant improvement in self-rated job performance (31.8%) or
ost savings of $7508 per employee per year. Conclusions: We con-
rmed that significant productivity loss arises from MDD and that this
oss can be reducedwith psychiatric intervention after a time period as
hort as 8 weeks. Mental health professionals should work with em-
loyers to devise a cost-effective system to provide workers with ac-
essible quality care.
eywords: cost, depression, lost productive time, productivity,
resenteeism.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Depression is one of the most prevalent health problems in the
workplace. A recent report from the Office of Applied Studies of
Substance Abuse and Mental Health Services Administration
showed that 7.0% of adult full-time workers (10.1% for women vs.
4.7% for men) experienced a major depressive episode (MDE) dur-
ing the past year [1]. Among workers in the United States, 6.4%
have been reported to meet the criteria for major depressive dis-
order (MDD) [2], and 4.6% of working Canadians have been re-
ported to meet criteria for an MDE during the past year [3].
Depressive disorders have been found to cause the largest dis-
ease burden (expressed as disability-adjusted life years, a stan-
dard burden of disease measure) in the working population of the
United States [4]. Due to the early age of onset and the chronic
course of illness, depressive disorders have a large influence on
work productivity [5]. Three major cost categories are used to es-
* Address correspondence to: Jong-Min Woo, Department of Psyc
Seoul, Republic of Korea 100-032.
E-mail address: jongmin.woo@gmail.com.
1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.timate the economic burden of depression: direct costs (e.g., med-
ical expenses), indirect costs (e.g., costs associated with depres-
sion in the workplace like reduced productivity), and mortality
costs arising from depression-related suicides [4]. Among these
three categories, indirect costs are estimated to be as high as or
evenhigher thandirect costs inmental health problems, including
depression [6,7]. The economic burden of depression in 2000 in the
United States was estimated at $83.1 billion, which consisted of
$51.5 billion (62%) in indirect workplace costs, $26.1 billion (31%) in
indirectmedical costs, and $5.4 billion (7%) in suicide-relatedmor-
tality costs [4].
Regarding indirect costs, many studies use the concept of
lost productive time (LPT), which consists of “absenteeism” and
“presenteeism.” Absenteeism refers to the LPT caused by hours
or days missed from work (e.g., tardiness, leaving work early,
sick leave) [7]. Presenteeism is defined as the estimated LPT
caused by reduced work performance while at work [8], which
can be brought on by decreased concentration, reduced motiva-
y, Inje University Seoul Paik Hospital, 85 Jeo-dong-2-ga, Jung-gu,
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
476 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 4 7 5 – 4 8 2tion, fatigue, or errors in decision making. Presenteeism is usu-
ally measured through surveys from employees, with measure-
ments varying in complexity from single items assessing time
spent at work while unwell, to multiple items incorporating
employee perceptions of productivity as related to their own
previous performance or to that of their colleagues [9,10]. For
depressive disorders, LPT from presenteeism has been shown to
exceed LPT from absenteeism. One study found that 81% of the
LPT among workers with depression was due to presenteeism,
whereas another study estimated the indirect costs of depres-
sion at $32.5 billion—$24 billion due to presenteeism and $8.5
billion due to absenteeism [7,11].
Recently, an increasing number of clinical trials focusing on
the treatment of MDD have shown favorable effects of interven-
tion and have suggested preferable return-on-investment (ROI)
results [12–15]. However, poor awareness and social stigma af-
fect workers’ access to quality care for MDD [16]. Thus, under-
standing themagnitude of lost productivity related to MDD, and
the benefits of treatment in reducing LPT, will help to guide
decisions about the allocation of additional resources or the
provision of accessible care to this population.
In this research, we estimated the loss of work productivity
among employees with MDD who visited psychiatrists in Seoul,
Korea, using the World Health Organization’s Health and Work
Performance Questionnaire (HPQ) [10]. We compared their LPT
with the LPT of a sample of healthy working controls, and we
measured the amount of recovered productivity after 8 weeks of
antidepressant treatment in an outpatient psychiatric setting.
Methods
Subjects
A total of 106 employees aged 20 to 60 years were screened from
four outpatient psychiatric clinics located in highly industrialized
districts in Seoul, Korea, using consecutive sampling technique.
Those patientswhomet theDiagnostic and StatisticalManual ofMen-
tal Disorders, 4th edition (DSM-IV), diagnostic criteria for MDD using
the Korean version of Structured Clinical Interview for DSM disor-
ders [17], were eligible for inclusion. Patients with MDD who were
already taking antidepressant medications were excluded. Pa-
tients with a history of MDD but not currently taking a psychiatric
medication, and displaying symptoms of a current depressive ep-
isode were included. Four patients withmedicosurgical disease orFig. 1 – Calculation of the cost of lost productive tother psychiatric disorders other thanMDDwere excluded. A total
of 102 subjects with MDD were then enrolled in the study, with
informed consent provided.
For the comparison group, age- and sex-matched healthy em-
ployees were recruited from the same region through advertising
in local newspapers and on websites. Approximately 150 volun-
teers were initially screened using the Korean version of Struc-
tured Clinical Interview for DSM disorders and, among them, a
group of 100 individuals with a similar age and sex distribution
who did not have significant medical of psychiatric illnesses were
recruited. Severe job stress and impending life events including
job loss can confound the results of productivity measures, thus,
nine healthy volunteers were excluded from the data analysis.
Thus, 91 subjects completed the questionnaires andwere enrolled
as the comparison group. Each subject provided informed consent
for his or her participation in this study after it had been fully
explained. The institutional review board of Inje University Seoul
Paik Hospital approved this study.
Treatment and assessment
The entire study population was assessed at baseline, and the
MDD group was also assessed at study weeks 4 and 8. Out of the
102 subjects in theMDD group, 35 patients dropped out after base-
line assessment and 15 patients dropped out betweenweeks 4 and
8. Fifty-two subjects completed assessments at baseline andweek
8 as well as after 8 weeks of treatment for MDD with antidepres-
sants and 20 to 30 minutes of supportive psychotherapy. They
were included in a complete analysis to measure changes after 8
weeks of treatment. Among them, 10 patients missed the week 4
visit, and, thus, we performed a complete analysis for 42 subjects
to compare changes among weeks 0, 4, and 8.
Measurement of health and productivity
We applied the Korean version of the HPQ for measurement of
productivity. The Korean version of the HPQ was developed using
conventional techniques of translation and back-translation by
bilingual psychiatrists, maintaining equivalence with the permis-
sion of the original author. There are other available instruments
for estimating absenteeism and presenteeism [18,19], but they are
limited by their complexity and narrow scope [20,21].
The HPQ was developed to avoid these limitations and has
been reported as valid and reliable [10]. It consists of three major
parts (questions about health, productive time, and demograph-
ics), and most of the questions address the previous 4-week pe-ime due to absenteeism and presenteeism.
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477V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 4 7 5 – 4 8 2riod. Absenteeism due to MDD is considered the sum of the num-
ber of absent work days due to health problems multiplied by 8
hours a day and the number of partial-day absences due to health
problemsmultiplied by 4 hours a day (Fig. 1). Presenteeism ismea-
sured by the self-rated level of job performance, a visual analogue
scale from 0 (worst) to 10 (best), during the past 4weeks. To ensure
the precise appraisal of presenteeism, the HPQ asks participants
for an estimate of colleagues’ average productivity and for their
own average productivity in the past year or two. Excess LPT from
MDD was calculated as the difference between the average LPT in
the MDD group and the average LPT in the comparison group.
Measurement of depressive symptoms
We used the Hamilton Rating Scales for Depression (HAM-D) to
measure the severity of depressive symptoms at baseline, week 4,
and week 8 [22].
Calculation of the annual cost of LPT due to absenteeism and
presenteeism
Absent work days because of health problems are assessed sep-
arately from those due to other reasons. LPT due to absenteeism
is estimated by summing up absent work days multiplied by 8
hours per day and partial missing days multiplied by 4 hours per
day. The annual cost of LPT due to absenteeism is calculated by
projecting total hours missed from work due to health problems
during a year, multiplied by the study subject’s own hourly wage.
Because the comparison group’s LPT due to absenteeism is con-
sidered the standard in this study, the cost of LPT due to absen-
teeism from MDD is calculated as the differences of the costs of
LPT due to absenteeism between the MDD group and the compar-
ison group (Fig. 1).
LPT due to presenteeism is quantified as the actual work hours
multiplied by the reduced performance level (productivity rating
during the past 4 weeks) divided by 10. The annual cost of LPT due
to presenteeism is estimated as the total hours lost from reduced
performance for a year multiplied by the study subject’s own
hourly wage (Fig. 1). The cost of LPT due to presenteeism can be
calculated by the same method used in absenteeism. Finally, the
total cost of LPT from MDD is calculated as the sum of the cost of
LPT due to absenteeism and the cost of LPT due to presenteeism.
Statistical analysis
We performed t tests, chi-square tests, and analysis of variance
tests depending on whether the variables were continuous or cat-
egorical, comparing subjects’ demographic data and the data from
the HPQ.We compared the comparison group to theMDD group at
baseline, and the MDD group before and after treatment. All sig-
nificance levels reported were two-tailed and the criterion for sta-
tistical significance was P  0.05. SPSS version 13.0 was used for
the statistical analysis.
Results
Comparison between employees with MDD and healthy
controls
There is no statistically significant difference between the MDD
group and the comparison group in terms of demographic and
work-related variables (Table 1). The severity of depressive symp-
toms asmeasured by theHAM-D is significantly higher in theMDD
group than in the comparison group (24.05 vs. 6.27; t  23.6, df 
91, P  0.001) (Table 2). The expected work hours per week on
average is 47.26 hours in the MDD group, which is significantly
higher than the 42.43 hours in the comparison group (t 2.65; P
.009). However, actual work hours per week are not statisticallyignificantly different between the MDD group and the compari-
on group (48.09 hours vs. 45.01 hours; t 1.29; P  0.196). Multi-
variate analysis using the demographic variables as predictors and
the prevalent depression as the dependent variable indicated that
only education showed a statistically significant contribution to
prevalent MDD (P  0.004).
Absent work days due to health problems during the past 4
weekswere significantly higher in theMDDgroup compared to the
comparison group, both in the number of absent work days (0.94
vs. 0.10; t 2.46, P 0.015) and the number of partialmissingwork
ays (2.56 vs. 0.24; t  4.25, P  0.001). Absent work days for any
other reason during the past 4weeks alsowere significantly higher
in the MDD group compared with the comparison group (full days
0.68 vs. 0.20; t 2.27, P 0.011; partial days 0.38 vs. 0.24; t 0.854,
P  0.535). However, total actual work hours during the past 4
weeks are not statistically significantly different between the two
groups (184.48 vs. 174.81 hours; t  1.11, P  0.267).
Regarding presenteeism, the MDD group rated their job perfor-
mance during the past 4 weeks as significantly lower than did the
Table 1 – Demographic data of workers with major
depressive disorder (MDD) and control group.
MDD
group
(n  102)
Control
group
(n  91)
P*
Age (y) 35.78 33.25 0.064
Sex
Man 51 44 0.819
Woman 51 47
Marital status
Unmarried 41 45 2 4.02, P  0.134
Married 51 43
Divorced 10 3
Education
Junior high school 4 1 2 19.90, P  0.000
High school 22 3
University 61 60
Graduate school 14 27
Religion
None 46 34 2 3.79, P  0.286
Protestant 29 38
Catholic 17 12
Buddhism 10 7
Shift work
Regular daytime 89 77 2 1.34, P  0.512
Fixed shift 4 2
Variable work hours 9 12
Employment status
Regular 80 67 2 0.61, P  0.434
Nonregular 22 24
Company size
Small* 59 46 2 1.03, P  0.310
Larger 43 45
Rank
Staff 42 44 2 2.25, P  0.522
Assistant manager 16 14
Manager 16 16
General manager 28 17
Duration of employment 6.87 y 5.52 y 0.135
Annual salary (US$)
15,000 24 22 2 0.95, P  0.918
15,000–24,999 21 22
25,000–34,999 22 21
35,000–44,999 16 13
45,000 19 13
* The number of employees is less than 50.comparison group (5.16 vs. 7.62; t 9.01, P 0.001). TheMDDgroup
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years as 6.63, which indicates that depressed employees rate their
own recent performance level as decreased by 22.18% when they
seek psychiatric help compared to previous levels. The compari-
son group did not show a significant difference in their job perfor-
mance between the past 4 weeks and the past year or 2 years (7.62
vs. 7.70; t  0.623, P  0.535).
We assessed the LPT and calculated costs from both absentee-
ism and presenteeism. The LPT due to absenteeism during the
past 4 weeks was 24.75 hours in the MDD group, and 4.27 hours in
the comparison group. The annual cost of absenteeismwas calcu-
lated as $4405 per person in theMDDgroup, and $725 per person in
the comparison group. The average annual per-employee cost of
absenteeism due to MDD can be calculated as $3680.
The LPT due to presenteeismduring the past 4weekswas 86.35
hours in the MDD group and 43.07 hours in the comparison group.
The annual cost of presenteeism was estimated to be $13,396 per
employee in the MDD group, and $6,967 per employee in the com-
parison group. Thus, the average annual per-employee cost of
presenteeism due to MDD can be calculated as $6429. The total
average annual cost of LPT due to MDD (including absenteeism
and presenteeism) was $10,109 per employee, which corresponds
to 33.4% of the mean annual wage in the MDD group ($30,275).
Table 2 – Control group vs. major depressive disorder (MD
17-item Hamilton Rating Scale for Depression
Actual work h/wk
Expected work h/wk
Absent work days due to health problems in the past 4 wk
Absent work days for any other reason in the past 4 wk
Partial missing work days due to health problems in the
past 4 wk
Total actual work hours during the past 4 wk
Self-rated job performance during the past 4 wk
Lost productive time due to absenteeism over the past 4 wk
LPT due to presenteeism during the past 4 wk
Annual cost of absenteeism
Annual cost of presenteeism
Annual cost of lost productive time‡
* Significant at P  0.05.
† Data are given as mean (SD).
‡ Annual cost of absenteeism plus annual cost of presenteeism.
Table 3 – Changes after 8 wk of psychiatric treatment in th
Be
17-item Hamilton Rating Scale for Depression
Actual work h/wk
Expected work h/wk
Absent days due to health problems during the past 4 wk
Absent days for any other reason during the past 4 wk
Partial missing days due to health problems during the
past 4 wk
Total actual work hours during the past 4 wk
Self-rated job performance during the past 4 wk
LPT due to absenteeism during past 4 wk
LPT due to presenteeism during past 4 wk
Annual cost of LPT due to MDD (US$)
LPT, lost productive time.
* Data are given as mean (SD).Changes in depressive symptoms and LPT after 8 weeks of
treatment with antidepressants
Among the 102 patients with MDD evaluated at baseline, 67
(66%) patients completed baseline and week 4 assessments,
whereas 52 (51%) completed baseline and week 8 assessments.
Forty-two (41%) subjects completed all three assessments
(weeks 0, 4, and 8), as well as 8 weeks of treatment for MDD. Of
the 50 subjects who did not complete treatment, reasons were
as follows: 14 (28%) refused treatment or sought it elsewhere, 10
(20%) reported significant improvement and felt no need for
further treatment, 10 (20%) were laid off or were on long-term
medical leave and thus could not be assessed for presenteeism,
7 (14%) complained of time constraints preventing them from
attending treatment sessions, 4 (8%) reported side effects, 1 (2%)
became pregnant, and 4 (8%) were lost to follow-up. A subset of
10 patients completed 8 weeks of treatment, but only completed
assessments at baseline and at week 8. When the 52 MDD sub-
jects who completed the trial were compared at baseline with
the 50 who did not, there was no statistically significant differ-
ence in any demographic or clinical variable.
The 52 MDD patients who completed the trial show almost the
same severity of depression andwork productivitymeasurements
oup at baseline.
rol (n  91) MDD (n  102) t P
.27 (4.99) 24.05 (5.40) 23.67 0.001*
.01 (15.06) 48.07 (17.01) 1.30 0.196
.43 (11.77) 47.26 (12.46) 2.65 0.009
.10 (0.61) 0.94 (3.16) 2.60 0.015
.20 (0.58) 0.68 (1.67) 2.67 0.011
.24 (0.80) 2.56 (5.10) 4.47 0.001*
.81 (57.38) 184.48 (59.45) 1.11 0.267
.62 (1.35) 5.16 (2.23) 9.26 0.001*
.27 (12.11) 24.75 (37.33) 5.16 0.001*
.07 (30.05) 86.35 (48.08) 7.36 0.001*
.51 (228.68) 440.55 (831.88) 4.17 0.001*
.74 (540.22) 1339.58 (895.68) 5.93 0.001*
12 (6,086) 17,989 (13,781) 6.51 0.001*
jor depressive disorder (MDD) group (n = 52)*.
treatment After treatment t P
0 (6.16) 7.19 (3.99) 18.91 0.001*
2 (17.68) 45.58 (15.00) 0.98 0.333
6 (11.81) 44.69 (10.08) 2.02 0.052
9 (3.45) 0.06 (0.31) 2.10 0.041*
2 (1.87) 0.12 (0.38) 2.75 0.008*
8 (4.94) 0.24 (1.42) 3.18 0.003*
3 (61.17) 175.27 (56.06) 0.04 0.969
0 (2.27) 6.46 (1.74) 7.01 0.001*
6 (40.35) 2.82 (7.93) 4.03 0.001*
5 (46.19) 61.58 (39.69) 4.21 0.001*
1,046 3,628 5.74 0.001*D) gr
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479V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 4 7 5 – 4 8 2as those of the MDD group as a whole at baseline (Table 3). After 8
weeks of antidepressant treatment with supportive psychother-
apy, HAM-D scores significantly improved (24.00 vs. 7.19; t 18.90,
 0.001). The average actualwork hours perweek did not change,
lthough the average expected work hours per week decreased
ith a marginal statistical significance (t  2.02, P  0.052). The
umber of absentwork days due to health problems and those due
o any other reason significantly decreased after 8 weeks of treat-
ent (t 2.10, P 0.041; t 2.75, P 0.008). The number of partial
bsent days due to health problems during the past 4 weeks also
ecreased (t  3.18, P  0.003). However, the actual work hours
uring the past 4 weeks did not change. The self-rated job perfor-
ance significantly increased from 4.90 to 6.46 (t 7.01, P 0.001),
hich can be compared to the average performance estimate of
.63 during the past year or 2 years in the MDD group.
We compared the treatment group at weeks 4 and 8 with base-
ine to assess the effects of psychiatric treatment. The severity of
DD assessed by the HAM-D and productivity measures, includ-
ng partial absenteeism due to medical reasons and self-rated job
Table 4 – Changes after 4 and 8 wk of antidepressant treat
Befor
17-item Hamilton Rating Scale for Depression 23
Actual work h/wk 48
Expected h/wk 47
Absent days due to health problems during the past 4 wk 1
Absent days for any other reason during the past 4 wk 0
Partial missing days due to health problems during the
past 4 wk
2
Total actual work hours during the past 4 wk 179
Self-rated job performance 4
* Data are given as mean (SD).
Fig. 2 – Graphic representation of a change of lost productive
major depressive disorder (MDD), compared to control group.erformance, were reduced in repeatedmeasures analysis of vari-
nce with a statistical significance (Table 4).
Discussion
Our results show that the employees with MDD lost more produc-
tive time due to both absenteeism and presenteeism than the
comparison group and that this loss was reduced by short-term
antidepressant treatment with supportive psychotherapy (Fig. 2).
The employees with MDDmissed approximately 25 hours dur-
ing the past 4 weeks on average because of health problems,
whereas the comparison groupmissed about 4 hours of work. The
group with depression also had more absent days for reasons
other than health. By definition, absenteeism caused byMDDdoes
not include absences due to non-health reasons. Given the perva-
sivemental and physical effects of MDD, it may contribute to non-
health-related absences. For example, an employee’s concern
about any disadvantages they could get from being noticed for
t in the major depressive disorder group (n = 42)*.
atment Week 4 Week 8 F P
.05) 12.05 (4.16) 6.60 (3.86) 165.58 0.000*
8.81) 46.17 (16.80) 45.17 (15.04) 1.77 0.186
2.08) 45.60 (10.23) 44.98 (10.21) 3.61 0.046
.39) 0.13 (0.46) 0.02 (0.15) 2.55 0.117
.02) 0.52 (2.00) 0.14 (0.42) 2.39 0.114
.54) 0.20 (0.83) 0.29 (1.57) 7.55 0.005
2.04) 179.21 (65.53) 177.79 (55.17) 0.04 0.961
.27) 5.88 (1.75) 6.45 (1.76) 25.55 0.000*
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480 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 4 7 5 – 4 8 2their depression could lead them to use personal leave rather than
sick leave. In addition, employees may have already used up sick
leave and must use other types of leave, such as personal leave.
Thus, increased nonhealth-related absences can be considered as
an alternate form of presenteeism. We have excluded absentee-
ism for non-health reasons fromour calculation of LPT and related
cost, but the loss would be more than our estimation had we in-
cluded these. Our final annual cost of LPT due to absenteeism from
MDD is estimated at $3680, which is 12.2% of the workers’ average
annual salary.
Depressed workers rated their own work productivity as 32.3%
lower than the comparison group on average. They also reported
that their performance during the past 4 weeks as 22.2% lower
than during the past year or 2 years. LPT frompresenteeism due to
MDD corresponds to 43.3 hours per 4 weeks. This result suggests
that MDD significantly affects the employees’ work performance
and thus reduces productivity. Each worker with MDD cost the
employer an average of $6429 per year from presenteeism, with
healthy controls’ productivity used as baseline, which corre-
sponds to 21.2% of his or her annual salary. The cost of LPT due to
MDD is estimated at $10,109 per year (33.4% of annual salary), with
presenteeism costs of $6429 per year, which exceeds the $3680
cost of absenteeism. These results are consistent with previous
studies reporting larger cost of lost productivity due to presentee-
ism than due to absenteeism in depression [23].
Because this study was performed in Korea, the US dollar esti-
mates are not entirely representative of what costsmight be in the
United States. To add some perspective, the Gross Domestic Prod-
uct (GDP) per capita for the Republic of Korea was $20,015 in 2007,
compared with GDP per capita of $41,890 in the United States. If
similar results were found in the US working population, one
could expect costs and cost-savings of almost twice the magni-
tude, given the roughly 1:2 ratio of GDP per capita of Korea to the
United States.
The fact that an employee present at work can cost the orga-
nization more than an absent employee supports the need for
aggressive and active intervention. In severe cases, especially, pa-
tients cannot get restored by passive intervention, such as adjust-
ments in working environment, less working time, or less respon-
sibility. EmployeeswithMDDare probably doing the best they can,
but are limited in what they can accomplish due to their depres-
sive symptoms. Ultimately, when absent fromwork, an employee
can potentially rest or use health care services. Absenteeism may
contribute to improvement of symptoms and restoration of job
performance. However, presenteeism results in added stress and
pressure upon employees, as they receive no treatment while at
work, negatively affecting their overall health. A previous cohort
study [24] investigating 5071 employees found that generally ill
eople with no absenteeism had two times the risk of heart attack
han those with some absenteeism. This supports the idea that
hile absenteeism means one is away from the work place, and
hus not productive, it may contribute to overall health by allow-
ng for time to receive health care services and restore health.
onsidering that depression often causes amyriad of non-specific
ymptoms, rather than a specific physical malady, patients are
ess likely to seek care. Depression and other mental health disor-
ers carry social stigma, and thus patients often end up suffering
hrough it rather than asking for sick leave, causing reduced pro-
uctivity and preventing improvement of symptoms. Both the
osts to the employer and risks to the employee seem to be far
reater in presenteeism than in absenteeism.
Eight weeks of treatment with antidepressants and supportive
sychotherapy decreased depressive symptoms as well as in-
reased productivity. Both absenteeism and presenteeism de-
reased significantly, resulting in a projected cost savings of $7418
nnually per employee. The HAM-D scores improved from an av-
rage of 24.0 at baseline, to 12.8 and 7.1 at 4 and 8 weeks, respec- dively. Seven is the upper limit for remission, thus it appears that
he treatment group had on average nearly achieved remission
rom their depressive episode. The group’s job performance scores
eflected a similar trend, increasing from 4.86 at baseline to 5.88 at
weeks to 6.46 at 8 weeks. The 8-week performance rating ap-
roached the 6.63 rating of self-reported performance during the
ast year or 2 years, indicating that after only 8 weeks of treat-
ent, these employees with MDD had almost achieved their pre-
ious job performance levels. Symptom reduction generally pre-
edes the improvement in social functioning, so productivity
easures were likely to improve further with extended follow-up,
s patients achieved remission. Indeed, selective serotonin re-
ptake inhibitors have beennoted to take 6 to 12weeks to have full
ffect, so it is likely that extending the treatment period past 8
eeks would have shown continued improvement in symptoms
nd productivity.
The MDD group rated their work performance during the past
ear or 2 years at 6.63, which was lower than the comparison
roup’s rating of 7.62. It is very possible that the MDD group was
xperiencing depression, subclinical or clinical, at that time, as it
s a chronic disorder. In addition, given that when they reported
hese numbers, they were all diagnosed with MDD, and they may
ave underestimated past performance due to current negative
iews of self. This difference, however, suggests that though em-
loyees may not have MDD, subclinical depression may cause re-
uced work performance, and, thus, it may be valuable to screen
idely among the workplace and offer an array of interventions.
One concern with MDD treatment is that despite the proven
enefits of antidepressant treatment, compliance rates remain
ow. Indeed, 20% of our treatment group dropped out due to work
esponsibilities and time constraints. This suggests that compli-
ncewould improvewithmore accessible and efficient psychiatric
are, and thus points to the need for psychiatric services to be
ntegrated into the workplace.
One interesting result is the actual number of hours worked by
he MDD group. At baseline, the MDD group worked significantly
ore than the comparison group (184.5 vs. 174.8), whileworking at
less productive rate. It is possible that because of decreased per-
ormance, the MDD spent more time at work trying to accomplish
imilar tasks. Decreased concentration may play a large role in
educing efficiency, which leads to increased time spent at work.
dditionally, because theMDD group hadmore absenteeism, they
ay have felt obligated to work more to make up for the missed
ork hours.
However, when looking at the MDD group who completed
reatment, their pretreatment work hours were similar to the
omparison group (175.5 vs. 174.8). Thus, the MDD group who did
ot complete treatment had a significantly higher number of work
ours (roughly 195). This dropout group had several subjects who
ot laid off and/or had other environmental stressors preventing
hem from continuing treatment. It is possible that their job situ-
tions entailed increased work hours to avoid lay-offs or other
onsequences.
The MDD group members who completed treatment worked a
imilar number of hours as the comparison group before treat-
ent, as well as after (175.5 vs. 175.3), while increasing their per-
ormance from 4.86 to 6.46. It is important that despite increas-
ng productivity, they were working just as much as before,
esulting in ultimate cost savings. If they were more productive,
ut worked fewer hours, they might have accomplished the
ame number of tasks as before treatment. However, our study
ndicates that in decreasing presenteeism, absenteeismwas not
ncreased, and is in fact decreased significantly (25.76 to 2.82).
fter just 8 weeks of treatment, absenteeism was reduced by
9.1% and presenteeism by 28.0%, showing significant gains to-
ard increasing overall productivity and reducing costs of LPT
ue to MDD.
481V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 4 7 5 – 4 8 2Our study has an advantage in thatwe quantified themonetary
value of the increased productivity time from short-term antide-
pressant treatment with supportive psychotherapy. We also de-
fined the MDD group as workers who met the DSM-IV diagnostic
criteria for MDD, excluding workers with subclinical depressive
symptoms. Many reports fail to clearly define psychiatric disor-
ders, like MDD, creating unnecessary confusion when discussing
or comparing different disorders. By clearly defining our study
population as patients who met the DSM-IV criteria for MDD, we
could more definitively compare the costs (whether due to LPT,
direct medical, and so on) of MDD with costs of other health con-
ditions.
As randomsamplingwas very difficult to achieve in this kind of
clinical study, we applied consecutive sampling to select every
available subject in a given period of time to minimize possible
selection bias from non-probability sampling. We also used fre-
quency matching to ensure that the MDD group and the compar-
ison group had the same distributions over strata defined by
matching factors (i.e., age, sex). Other demographic and work-re-
lated variableswere quite similar and thusmade these two groups
comparable.
The most significant limitation in the interpretation of our
finding was that our study population only covered employees
with a diagnosis of MDDwho could visit psychiatrists while main-
taining their jobs. Our sample may not represent all the employees
withMDDat theworkplace. Excess LPT due toMDD in our studywas
higher than the 5.6 hours per week of health-related LPT among
workers with depression who participated in the American Produc-
tivity Audit [7]. It may be related to a higher severity of depression in
our subjects, because they were from a patient population who vol-
untarily visited psychiatrists, instead of a community-based popula-
tion.A selectionbias exists in our studypopulation, because employ-
ees with chronic MDD who had already lost their job, suicidal
patients, and those who did not seek psychiatric care voluntarily
were all excluded. Indeed, all of the participants were informed
enough to recognize symptoms, willing to seek treatment, and able
to access treatment from a financial and work standpoint.
A second limitation of our studywas that we did not include an
appropriate comparison group—workers with MDD who receive
placebo or psychotherapy alone—to evaluate improvement after
the outpatient treatment of MDD. However, it was impossible to
recruit such a comparison group due to ethical issues. Most im-
portantly, the primary focus of this study is to assess the effect of
the treatment on work productivity among the MDD patients in a
real-world clinical practice, not an experimental setting, and esti-
mate themonetary value of it. Considering the current health care
environment in Korea and the primary aim of our study, the best
option that we could choose was the inclusion of age- and sex-
matched healthy workers as a comparison group to compare the
improvement of work productivity after treatment of MDD pa-
tients. In comparing the change in patients with a secular trend, it
is not exactly showing what the effect of treatment is, but it is
showing the maximum possible effect of treatment. And, it does
also clearly reflect the change as a result of treatment for a clini-
cally relevant population. It might be safe to say that the results of
this study can hold for the specific population with MDD whose
depression symptoms are severe enough to visit the psychiatric
clinic for 8 weeks, butmoderate enough tomaintain their jobs and
visit outpatient clinics.
A third limitation of the study was that our measures of lost
productivity are subjective, not objective. It is possible that sub-
jects’ appraisals of their job performance were influenced by how
they were feeling at the moment rather than by the “real” job
performance, applying negative and harsh appraisal at baseline
and overpositive job performance ratings as depressive symptoms
improve. However, the HPQ is widely used, and during the past
several years consistent findingswere reported inmany countries.Furthermore, we had no alternative than to use the best available
estimate of performance measurement, as either a comparison
with others or rating by others could not guarantee any further
objectiveness. The use of other information including quality of
life to model performance measurement is not recommended, as
the correlation between quality of life and productivity cost is not
strong [25]. Thus, we do not have any evidence that hampers the
validity of this subjective rating tool for job performance.
A fourth limitation of this study is that we did not take into
account the fact that compensating mechanisms exist for ab-
senteeism. We used participants’ wages to estimate productiv-
ity losses for the period of absence. Some researchers argue that
short-term absence can be often compensated for during the
normal working hours and thus does not cause productivity
losses [26]. We cannot deny the possibility of overestimating
LPT for absenteeism in this study. And the nonsignificant dif-
ference between groups regarding education and rank might
have influenced absenteeism, as compensating mechanisms
are suggested to vary by occupational characteristics.
Another limitation is that the extrapolation of 8 weeks of mea-
surement to 1 year might be biased, especially in cases where
patients are absent from work on and off which might be the case
in depression [27]. Furthermore, we assumed the preceding 4
weeks could be representative of the whole year. If we consider
the natural course of depression, it may not hold true. However,
we consecutively recruited the participants from 2005 to 2007,
and the time point of recruitment was spread out through the
year. Thus, seasonality of depressive episodes can be excluded.
In addition, the possibility of spontaneous remission during 8
weeks is very low. If some of the participants naturally got bet-
ter and vice versa, they seemed to drop out as shown in the
reasons for the dropouts.
Our research findings suggest that there is a lot of room for
improvement. We did not compare the costs from LPT with the
costs of the intervention; however, we could estimate the direct
medical costs incurred by the patients based on the data that we
could get from the hospital. The result suggested that the total
cost of the intervention among the patients who completed the
8-week treatment was estimated to be $334.25  $159.28 per
patient, and the cost for the dropouts was $119.22  $91.96 per
person. If we consider only out-of-pocket expenses, the com-
pleters were estimated to spend $133.70  $63.71, and the drop-
outs were estimated to spend $47.69  $36.78 [28,29]. Recent
studies suggest that the costs of depression treatment may be
offset by an improved bottom line from increased worker pro-
ductivity and reductions in other health care expenses [15,30].
Indeed, Lo Sasso et al. [31] also reported an ROI of $3 for every $1
invested in enhanced depression care. Depressive disorders are
among themost common health problems, and employees have
no clear way out of them. There are several obstacles to receiv-
ing optimal care, such as social stigma toward mental health
conditions, time constraints, and fear of uncovering private dif-
ficulties. As depressive disorders cause more functional impair-
ment and productivity loss than any other illness, attention and
investments from multiple stakeholders would be needed to
address and treat employees’ mental health, thereby increasing
the productivity of the organization.
Our sample showed quite a high dropout rate in comparison
with other clinical trials. Thirty-five subjects dropped out between
baseline and 4 weeks, and 52 patients followed up at 8 weeks (15
subjects dropped out between 4 weeks and 8 weeks). The low re-
sponse rate (51%) in this study limits generalizability of the results
from the study. Though the dropout ratewas high, comparisons of
the baseline group with the week 4 and week 8 intervals indicated
that most of the results were similar, and thus, did not seem to
introduce major bias in the study. Furthermore, this dropout rate
was similar to the recently reported adherence rate of the patients
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482 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 4 7 5 – 4 8 2with MDD taking selective serotonin reuptake inhibitors, which
amounts to only 17.9% throughout the first 3 months of treatment
[32]. Ifweassumeanevendistributionofdropoutsover 3months,we
would expect 45.3% of adherence rate among our study population
and this is very similar to the 51.0% follow-up rate at 8 weeks (52 out
of 102) from our data.
Preventing and managing mood disorders among workers is
the principal issue. Organizational efforts can save money while
creating a healthier, happier, and more productive workplace. If a
worker in the service industry is not happy, then he or she cannot
smile at the customers, cannot be kind enough, can ruin the rela-
tionship with them, and could lose the sale as a result. If a re-
searcher in the information technology industry is not emotion-
ally healthy or stable, he or she cannot generate creative and
feasible ideas and thus cannot be productive.
Further studies are needed to estimate employer ROI and the
cost-benefit of managing depressive disorders in the workplace,
and to foster awareness of positive implications for employees,
employers, their families, and society at large.
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